Dosing has begun in a long-term extension study testing Satellos Bioscience’s experimental oral therapy SAT-3247 in men with ...

Columnist Betty Vertin doesn't often dwell on her caregiver grief, but sometimes she needs to embrace it and let it flow through her.

In a $12 billion deal, Novartis has agreed to acquire Avidity Biosciences, which is developing several treatments for ...

As columnist Robin Stemple's FSHD progresses, he worries about how his increased care needs will affect his family caregivers ...

Learning how to talk to doctors about Duchenne muscular dystrophy can help support you in your role as a caregiver for ...

Bridgebio Pharma says it will seek U.S. approval of BBP-418 for LGMD2i after Phase 3 trial data showed a range of benefits ...

Use of the oral therapy BBP-418 appeared to improve walking ability and lung function in people with limb-girdle muscular dystrophy type 2i (LGMD2i) — characterized by muscle wasting at the shoulders ...

Learn how Duchenne muscular dystrophy affects oral health and explore tips for daily care, dental visits, and preventing ...

Advocating for Duchenne MD doesn't just mean testifying in Washington, D.C.. It also means giving what you can, says columnist.